Viewing Study NCT02581020


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-03-03 @ 11:21 AM
Study NCT ID: NCT02581020
Status: COMPLETED
Last Update Posted: 2021-12-08
First Post: 2015-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module